meloksikaam
ravim
üksikjuht nähtusest
type of chemical entity
kasutus
keemiline struktuur
mass/kaal
351,035 aatommassiühik[24]
chemical formula
C₁₄H₁₃N₃O₄S₂[3]
canonical SMILES
CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O[3]
isomeric SMILES
CC1=CN=C(S1)/N=C(/C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O)\O[22]
defined daily dose
active ingredient in
Vivlodex[26]
Metacam[27]
EloxiOral[28]
Ostilox[29]
Meloxidyl[30]
Mobic[31]
Loxicom[32]
World Health Organisation international non-proprietary name
meloxicam[2]
medical condition treated
osteoarthritis[33]
osteoarthritis susceptibility 1[34]
desmoid disease, hereditary[34]
significant drug interaction
physically interacts with
legal status (medicine)
boxed warning[39]
pregnancy category
Australian pregnancy category C
US pregnancy category C
Commonsi kategooria
Meloxicam
Viited
- ↑ Freebase Data Dumps, 28. oktoober 2013
- ↑ 2,0 2,1 2,2 2,3 ChEBI, 19. oktoober 2016, inglise keel, meloxicam, 6741
- ↑ 3,0 3,1 3,2 3,3 3,4 PubChem, 19. november 2016, inglise keel, 54677470, meloxicam
- ↑ 4,0 4,1 4,2 4,3 4,4 4,5 ZRVUJXDFFKFLMG-UHFFFAOYSA-N, InChIKey
- ↑ 5,0 5,1 UniChem
- ↑ 6,0 6,1 6,2 6,3 6,4 Global Substance Registration System, 19. november 2016, inglise keel, meloxicam, VG2QF83CGL
- ↑ Quora
- ↑ DrugBank, inglise keel, 17. november 2015, 00814, Meloxicam
- ↑ Hazardous Substances Data Bank, 10. mai 2021, 28. oktoober 2019, Meloxicam, 7741
- ↑ OpenAlex, 26. jaanuar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
- ↑ 11,0 11,1 ChEMBL, 19. november 2016, inglise keel, MELOXICAM, CHEMBL599
- ↑ CAS Common Chemistry, 7. aprill 2021, https://commonchemistry.cas.org/detail?cas_rn=71125-38-7, ZRVUJXDFFKFLMG-UHFFFAOYSA-N
- ↑ ChEBI release 2020-09-01
- ↑ Immune Epitope Database and Analysis Resource, 1. märts 2022, 613442
- ↑ International Chemical Identifier, InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)
- ↑ 16,0 16,1 ECHA Substance Infocard database, 27. detsember 2018, 100.113.257, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1λ⁶,2-benzothiazine-3-carboxamide, CAS no.: 71125-38-7
- ↑ 17,0 17,1 inferred from InChIKey
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 19. november 2016, inglise keel, 7220, meloxicam
- ↑ Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
- ↑ Protein Data Bank, 19. oktoober 2016, inglise keel, 4M11, 4M11
- ↑ Protein Data Bank, 19. oktoober 2016, inglise keel, 4O1Z, 4O1Z
- ↑ 22,0 22,1 ChemSpider, 19. november 2016, inglise keel, 10442740, Meloxicam
- ↑ N0000148649, 27. veebruar 2018, NDF-RT
- ↑ PubChem, 19. oktoober 2016, inglise keel, 54677470, meloxicam
- ↑ 25,0 25,1 25,2 https://www.whocc.no/atc_ddd_index/?code=M01AC06
- ↑ RxNorm, 1722350, 14. veebruar 2018
- ↑ RxNorm, 1086708, 14. veebruar 2018
- ↑ RxNorm, 1788847, 14. veebruar 2018
- ↑ RxNorm, 1482670, 14. veebruar 2018
- ↑ RxNorm, 1439977, 14. veebruar 2018
- ↑ RxNorm, 152699, 14. veebruar 2018
- ↑ RxNorm, 1364057, 14. veebruar 2018
- ↑ N0000148649, 13. detsember 2016, NDF-RT, inglise keel
- ↑ 34,0 34,1 34,2 Drug Indications Extracted from FAERS, 2. oktoober 2018
- ↑ 35,00 35,01 35,02 35,03 35,04 35,05 35,06 35,07 35,08 35,09 35,10 35,11 35,12 35,13 35,14 35,15 35,16 35,17 35,18 35,19 35,20 35,21 35,22 35,23 35,24 35,25 35,26 35,27 35,28 35,29 35,30 35,31 35,32 35,33 35,34 35,35 35,36 35,37 35,38 35,39 35,40 35,41 35,42 35,43 35,44 35,45 35,46 35,47 35,48 35,49 35,50 35,51 35,52 35,53 35,54 35,55 35,56 35,57 35,58 35,59 35,60 35,61 35,62 35,63 35,64 35,65 35,66 35,67 35,68 35,69 35,70 35,71 35,72 35,73 35,74 35,75 35,76 35,77 35,78 35,79 35,80 35,81 35,82 35,83 35,84 35,85 35,86 35,87 35,88 35,89 35,90 35,91 35,92 35,93 A reference set of clinically relevant adverse drug-drug interactions, hypothetically
- ↑ 36,00 36,01 36,02 36,03 36,04 36,05 36,06 36,07 36,08 36,09 36,10 36,11 36,12 36,13 36,14 36,15 36,16 36,17 36,18 36,19 36,20 36,21 36,22 36,23 36,24 36,25 36,26 36,27 36,28 36,29 36,30 36,31 36,32 36,33 36,34 36,35 36,36 36,37 36,38 36,39 36,40 36,41 36,42 36,43 36,44 36,45 36,46 36,47 36,48 36,49 36,50 36,51 36,52 36,53 36,54 36,55 36,56 36,57 36,58 36,59 36,60 36,61 36,62 36,63 36,64 36,65 36,66 36,67 36,68 A reference set of clinically relevant adverse drug-drug interactions, established
- ↑ 37,00 37,01 37,02 37,03 37,04 37,05 37,06 37,07 37,08 37,09 37,10 37,11 37,12 37,13 37,14 37,15 37,16 37,17 37,18 37,19 37,20 37,21 37,22 37,23 37,24 37,25 37,26 37,27 37,28 37,29 37,30 37,31 37,32 37,33 37,34 37,35 37,36 37,37 37,38 37,39 A reference set of clinically relevant adverse drug-drug interactions, probably
- ↑ 38,0 38,1 IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 7220, inglise keel
- ↑ FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links., https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
- ↑ N0000148649, 5. märts 2018, NDF-RT
- ↑ 41,0 41,1 Medical Subject Headings, 15. märts 2018, C065757